In Treatment

In Treatment

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our...
Cancer Journey:
Cancer Type:
Disease Learning:
For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our...
Cancer Journey:
Cancer Type:
Disease Learning:
For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our...
Cancer Journey:
Cancer Type:
For our Mandarin-speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our...
Cancer Journey:
Cancer Type:
Disease Learning:
For our Mandarin-speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our...
Cancer Journey:
Cancer Type:
Disease Learning:

Articles

Download slides from LIVE WEBCAST of November 18, 2017 in partnership with Georgetown University Hospital, GRACE presents: 2017 Advances in Immunotherapy: What Lung Cancer Patients Need to Know
Cancer Journey:
Cancer Type:
Head & Neck Cancers Frequently Asked Questions Written by Joshua Bauml, MD September 2017 What is it? “Head and neck cancer” is an umbrella term...
Cancer Journey:
Cancer Type:
Disease Learning:
Malignant Hematology Progress in understanding DNA changes in lymphoma has already provided improved and highly sensitive tests for detecting this...
Cancer Journey:
Cancer Type:
To many, the recent FDA approval of a combination of chemotherapy and concurrent immunotherapy for the vast majority of patients with advanced (metastatic) non-squamous non-small cell lung cancer (NSCLC) probably seems like a great idea.
Cancer Journey:
Cancer Type:
Disease Learning:
Dr. Jonathan Goldman joins GRACE to explain why carboplatin, pemetrexed and pembrolizumab has become his new go-to regimen for first-line non-squamous NSCLC treatment.
Cancer Journey:
Cancer Type:
Disease Learning:

Community Forum

I have psoriasis (along with my stage IV NSCLC ALK Positive) I am taking Alectinib for the NSCLC. Is it OK to take a biologic like Cosentyx, Stelara...
Cancer Journey:
Cancer Type:
Disease Learning:
I've been on Tagrisso since July 2017. I had great initial response with all visible cancer shrinking to the point of no longer being detected...
Cancer Journey:
Cancer Type:
Disease Learning:
My husband has the following values for kidney function: Creatinine: 1.36 (normal range .8 - 1.25) Urea: 68 (normal range 15 - 53) Would these values...
Cancer Journey:
Cancer Type:
Disease Learning:
Has anyone had mixed results from chemo/immunotherapy? My uncle was diagnosed with stage iv nsclc (exon 20 mutation). It has spread to the bones,...
Cancer Journey:
Cancer Type:
Disease Learning:
On Saturday, November 10, 2018, GRACE partnered with Swedish Cancer Institute to present a live and webcast discussion on Local Therapies for...
Cancer Journey:
Cancer Type: